| View |
|
DRP-12855-01
|
Cefuroxime (as axetil)
|
Zuri-125
|
125 mg/5 mL
|
Powder for Oral Suspension
|
Antibacterial (Cephalosporin)
|
Globela Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
12 May 2024
|
28 October 2027
|
| View |
|
DRP-13585-03
|
Levetiracetam
|
Golyptin
|
500 mg
|
Film-Coated Tablet
|
Antiepileptic
|
Zhejiang Jingxin Pharmaceutical Co. Ltd.
|
China
|
CLIDP Conversion
|
12 May 2024
|
14 March 2028
|
| View |
|
DRP-13983-07
|
Apixaban
|
Linoac
|
5 mg
|
Antithrombotic agent (Direct factor Xa inhibitor)
|
Antithrombotic agent (Direct factor Xa inhibitor)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
15 May 2024
|
31 May 2028
|
| View |
|
DRP-13984-06
|
Apixaban
|
Linoac
|
2.5 mg
|
Film-Coated Tablet
|
Antithrombotic agent (Direct factor Xa inhibitor)
|
Stallion Laboratories Pvt. Ltd
|
|
CLIDP Conversion
|
12 May 2024
|
31 May 2028
|
| View |
|
DRP-14088-08
|
Tobramycin (as sulfate) + Dexamethasone (as sodium phosphate)
|
Eyedex
|
3 mg/1 mg (0.3%/0.1% w/v) per mL
|
Sterile Ophthalmic Suspension (Eye Drops)
|
Antibacterial (Aminoglycoside)/Corticosteroid
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
12 May 2024
|
20 June 2028
|
| View |
|
DRP-14096-04
|
Clindamycin (as phosphate)
|
None
|
150 mg / mL
|
Solution for Injection (IM/IV)
|
Antibacterial (Lincosamide)
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
15 May 2024
|
20 June 2028
|
| View |
|
DRP-14215-02
|
Iron (as Iron sucrose)
|
None
|
20 mg/mL
|
Solution for Injection (IV)
|
Anti-anemic Preparation
|
Maxitech Pharma (Pvt.) Ltd
|
Pakistan
|
CLIDP Conversion
|
15 May 2024
|
27 July 2028
|
| View |
|
DRP-14708-01
|
Acetylcysteine
|
Flucysteine 600 Choco
|
600 mg per sachet
|
Powder for Oral Solution
|
Mucolytic
|
Unicure Remedies Pvt. Ltd.
|
India
|
CLIDP Conversion
|
15 May 2024
|
01 December 2028
|
| View |
|
DRP-14776-02
|
Norepinephrine (as bitartrate)
|
Aenor
|
2 mg/mL (8 mg/4 mL)
|
Solution for Injection (I.V. Infusion)
|
Adrenergic/ Dopaminergic Agent
|
Ultra Laboratories Private Limited
|
India
|
CLIDP Conversion
|
12 May 2024
|
03 January 2029
|
| View |
|
DRP-14892-01
|
Tobramycin + Dexamethasone
|
Kodex
|
3mg/1mg per mL
|
Ophthalmic Suspension (Eye Drops)
|
Antibacterial (Aminoglycoside)/Corticosteroid
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
12 May 2024
|
01 February 2029
|
| View |
|
DRP-4813-03
|
Glimepiride
|
Gliped
|
4 mg
|
Tablet
|
Blood Glucose-Lowering Drug (Sulfonylureas)
|
Lifesquare Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
12 May 2024
|
14 February 2029
|
| View |
|
DRP-4947-09
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Pizotaz
|
2 g / 250 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Penicillin with Beta-lactamase Inhibitor)
|
Inject Care Parenterals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
12 May 2024
|
22 November 2028
|
| View |
|
DRP-4961-24
|
Cefixime (as trihydrate)
|
Cefitrene 100
|
100 mg/5 mL
|
Powder for Suspension
|
Antibacterial (Cephalosporin)
|
Sakar Healthcare Ltd
|
India
|
CLIDP Conversion
|
12 May 2024
|
27 November 2028
|
| View |
|
DRP-5043-04
|
Fenofibrate
|
Fenomel
|
67 mg
|
Capsule
|
Hypertriglyceridemia
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
12 May 2024
|
07 January 2029
|
| View |
|
DRP-5841-01
|
Epirubicin hydrochloride
|
None
|
50 mg
|
Lyophilized Powder for Injection
|
Antineoplastic
|
Celon Laboratories Private Limited
|
India
|
CLIDP Conversion
|
13 May 2024
|
08 August 2029
|
| View |
|
DRP-7554-02
|
Irbesartan
|
Unbranded
|
150 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
12 May 2024
|
15 September 2029
|
| View |
|
DRP-8396-07
|
Omeprazole (as Sodium)
|
Ompraz
|
40 mg
|
Powder for Injection (IV)
|
Proton Pump Inhibitor
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
|
China
|
CLIDP Conversion
|
12 May 2024
|
19 November 2028
|
| View |
|
DRP-8595-02
|
Ampicillin (as sodium)
|
Ampiden
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Penicillin)
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
|
China
|
CLIDP Conversion
|
12 May 2024
|
20 December 2024
|
| View |
|
DR-XY35798
|
Nimesulide
|
Nidolid
|
20mg/g (2% w/w)
|
Transdermal Gel
|
Non-steroidal Anti-Inflammatory Drug (NSAID)
|
Polipharm Co., Ltd
|
Thailand
|
Renewal
|
18 May 2024
|
11 May 2029
|
| View |
|
DRP-10572-01
|
Cetirizine Hydrochloride
|
Regizine
|
2.5mg/mL Syrup (Oral Drops) (Grape Flavor
|
Syrup (Oral Drops) (Grape Flavor)
|
Antihistamine (Piperazine Derivative)
|
New Myrex Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
20 May 2024
|
18 October 2026
|